Selim M. Arcasoy, M.D., F.C.C.P.,
F.A.C.P.
Advanced lung disease and lung transplantation
|
|
R. Graham Barr, M.D., Dr.P.H.
Novel risk factors for asthma and chronic obstructive pulmonary disease (COPD) |
|
Robert C. Basner, M.D.
cardiopulmonary interactions awake and during sleep; cardiovascular complications of sleep deprivation; pathophysiology and treatment of
metabolic syndrome and obstructive sleep apnea syndrome
|
|
John P. Bilezikian, M.D.
Metabolic Bone Diseases, Primary Hyperparathyroidism, Osteoporosis, Mechanisms of Parathyroid Hormone Action
|
|
| Robert S. Brown, Jr., M.D., M.P.H. |
|
Matthew Burg, Ph.D.
The role of stress and emotion in CHD related prognosis, and the mechanisms underlying this role.
|
|
Olveen Carrasquillo, MD, MPH
Minority health, health disparities, health services research, health policy, access to care, and national health insurance
|
|
David J. Cohen, MD
Immunosuppressive drug protocols in renal transplantation, as well as renal disease occurring in recipients of non-renal
transplants
|
|
Harold Frucht, M.D.
The genetics, prevention, and early detection of gastrointestinal malignancies, and pre-neoplastic gastrointestinal diseases
|
|
Victor Grann, M.D.,M.P.H.
Health outcomes, cost-effectiveness and decision analysis, quality of life, and disparities of cancer care and
prevention.
|
|
Dawn Hershman, M.D., M.S
Clinical trials in breast and gynecologic malignancies, Supportive care and cancer survivorship
|
|
Steven Kawut, M.D.
Determinants and prediction of outcome for patients with pulmonary arterial hypertension and for patients
who are undergoing lung transplantation
|
|
Marianne J. Legato, M.D.
Delineating the differences in men and women's normal physiology and in their experience of the same diseases.
|
|
Jose Luchsinger, M.D.
Relationship between cardiovascular risk factors and cognition. Relationship between diet and cognition.
|
|
Mathew S. Maurer, MD
I am interested in understanding how age related changes in cardiovascular structure and function contribute to
cardiovascular disorders that disproportionately afflict the elderly.
|
|
Alfred I. Neugut, M.D., Ph.D.
Cancer epidemiology and prevention, mainly focused on the epidemiology of GI tract cancers and second malignancies.
Also cancer treatment in the elderly and access to care in underserved populations and health disparities for the
underserved.
|
|
Gwen L. Nichols, M.D.
Translational research in hematologic malignancies, laboratory efforts to forward clinical research protocols in leukemia,
lymphoma, myeloma and Waldenstrom's macroglobulinemia.
|
|
Gbenga Ogedegbe, M.D., M.P.H., M.S.
Minority Health Research. Improving Medication Adherence in Hypertensive African Americans.
|
|
Walter Palmas, M.D.
Telemedicine. Prevention of cardiovascular diseases. Effects of nutritional supplementation on chronic, low level serum
inflammation. Identification and causes of subclinical atherosclerosis.
|
|
Thomas Pickering, M.D., D.Phil.,
Behavioral aspects of hypertension and heart disease.
|
|
Jai Radhakrishnan, MD, MRCP
Glomerular disease esp. lupus nephritis. Chronic kidney disease.
|
|
David G Savage, MD
Investigations of the clinical features and treatment of the hematological malignancies, including multiple myeloma,
leukemia, and lymphoma.
|
|
Elizabeth Shane, M.D.
Osteoporosis and other disorders of bone and mineral metabolism. The multiple intersections between the skeleton
and other diseases (such as HIV/AIDS) and medications (glucocorticoids, cyclosporines, heparin).
|
|
Shonni J. Silverberg, M.D.
Investigation and management of disorders of bone and mineral metabolism. The clinical study of primary hyperparathyroidism,
including non-traditional as well as classical manifestations of the disease, and options for medical therapy.
|
|
Michelle P. Warren, MD
Effects of exercise and weight loss on the hypothalamic-pituitary gonadal axis and the metabolic signals to the GnRH pulse
generator, and on the development of osteopenia in women. Treatment of the menopausal woman. Effects of puberty on
behavior.
|
|
Judah Weinberger, M.D., Ph.D.
The translation of basic scientific advances into clinically useful therapeutic devices and drugs for the treatment of
cardiovascular disease.
|
